Captura Biopharma Team​

Michael B. Geranen

CEO, Co-Founder, Veteran, U.S. Army Ranger, 1/75th Ranger Regiment 91-95

• Experienced CEO with a demonstrated history in the pharmaceutical industry. Skilled in Finance and Product Development in the Branded and Generic pharmaceutical industry. Experienced working with the U.S. Food and Drug Administration (FDA), Strategic Planning and financial structuring to support development investment to-cash flow positive outcomes.
• Additional work in international markets, leveraging trade channels and strategic alliances across the globe. Most distinguished skill in developing novel financing mechanisms in support of on-going corporate activities and funding, in addition to government grants and tax incentives in support of Cash-Flow positive outcomes for the company.
• Early work as an analyst and a Managing Director, at Life Sciences Investment Bank. As an investment banker and consultant assisted many companies in the development and execution of their business models through various corporate development initiatives including business planning, competitive intelligence, market research, salesforce development, alliance management, and capital investment. Participated in over +100M in global transactions ranging from financing, M&A and Global Licensing.

Anthony Soscia

President, Co-Founder

Senior pharmaceutical leader with over 25 years of experience growing companies and portfolios in both the branded generic and generic space. Mr. Soscia has worked in all levels of the industry from API manufacturing to developing innovative therapies and hard to formulate product.   Extensive experience in active pharmaceutical ingredient and finished dosage development. Recognized as an expert in the field of abuse deterrent narcotic drug delivery, Mr. Soscia has invented and holds numerous patents in the field. Mr. Soscia has an extensive international network of finished dosage and active ingredient contacts and business development expertise. He is a creative entrepreneur with a flexible leadership style who will go to great lengths to realize a vision. Founded and grew multiple companies, including Atlantic Pharmaceuticals and Medicor Actives. In addition, he has held positions with Pfizer, Aceto Chemicals, Ampak, and Roussel UCLAF.

Dr. Gary Barnette

Ph.D., Regulatory

Dr. Barnette was Sr. Vice President of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services, LLC from 2012 to August 2018 and had responsibility of the oversight and development of scientific and regulatory drug development strategies across virtually all therapeutic areas, including urology, reproductive, oncology, cardiovascular, and analgesics/anesthetics. Dr. Barnette has held positions with GTx, Inc. including Vice President, Clinical Development Strategy.

Prior, Dr. Barnette was a Clinical Pharmacology and Biopharmaceutics Reviewer at the US FDA, receiving numerous awards for review, mentoring, and serving on various FDA guidance development groups and FDA initiative task forces. Dr. Barnette holds a Ph.D. in Basic Pharmaceutical Sciences (Clinical Pharmacology and Pharmacokinetics) from West Virginia University, School of Pharmacy

Dr. Peter Paganussi

MD, Chief Medical Officer

Dr. Paganussi has been practicing Emergency Medicine for over 30 years and is board certified in the specialty. He graduated from Fordham University with a B.S. in Biological Sciences and received a M.S. in Physiology & Biophysics and a M.D. from Georgetown University School of Medicine. He trained in Emergency Medicine and Cardiac Research at Henry Ford Hospital.

He has served as Chairman of the INOVA Health System IRB for over 14 years and has extensive background in human clinical research trials and he has served as a consultant for several Contract Research Organizations. His Emergency Medicine background includes knowledge & training in biohazards, radiation sickness, disaster medicine and toxicology.